VulnerabilityModified

CVE-2022-47376

The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation.

HIGH 7.3EPSS 0.16%

Does this matter?

High impact if exploited, but EPSS currently rates exploitation as unlikely (0.16%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.

Description

The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation. No patient health data is stored in the database, although some site installations may choose to store personal data.

CVSS 3.1: 7.3 HIGHCVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L
EPSS: 0.16% probability · 6th percentile
CISA KEV: Not listed
Weakness: CWE-257, CWE-522
Affected: bd/alaris infusion central
Source: cybersecurity@bd.com

References

https://www.bd.com/en-us/about-bd/cybersecurity/bulletin/alaris-infusion-central-recoverable-password-vulnerabilityVendor Advisory
https://www.bd.com/en-us/about-bd/cybersecurity/bulletin/alaris-infusion-central-recoverable-password-vulnerabilityVendor Advisory

Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.